Inhibrx Biosciences, Inc. short interest in 2026
In 2026, Inhibrx Biosciences, Inc.'s disclosed short interest ran from 11.35% of shares outstanding on 15 Jan 2026 to 23.06% on 15 Sep 2026, a change of +11.71 percentage points. The year's high was 23.60% on 30 Jun 2026 and its low 11.35% on 15 Jan 2026, averaging 18.20% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.64 days on 31 Jul 2026. Full history: Inhibrx Biosciences, Inc..
Cite this page
2026 in figures
- Start of year
- 11.35% (15 Jan 2026)
- End of year
- 23.06% (15 Sep 2026)
- Change
- +11.71 pp
- High
- 23.60% (30 Jun 2026)
- Low
- 11.35% (15 Jan 2026)
- Average
- 18.20%
- Highest days to cover
- 15.64 (31 Jul 2026)
- SEC filings marked
- 6
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 11.35% | 9.85 | |
| 30 Jan 2026 | 11.95% | 7.15 | |
| 13 Feb 2026 | 11.93% | 11.11 | |
| 27 Feb 2026 | 11.88% | 11.23 | |
| 13 Mar 2026 | 12.76% | 10.40 | |
| 31 Mar 2026 | 14.51% | 8.58 | 10-K filed, results (8-K) |
| 15 Apr 2026 | 14.63% | 8.66 | |
| 30 Apr 2026 | 18.71% | 3.97 | |
| 15 May 2026 | 20.08% | 4.48 | 10-Q filed, results (8-K) |
| 29 May 2026 | 21.77% | 9.32 | |
| 15 Jun 2026 | 22.59% | 10.25 | |
| 30 Jun 2026 | 23.60% | 9.91 | |
| 15 Jul 2026 | 23.51% | 9.04 | |
| 31 Jul 2026 | 22.87% | 15.64 | |
| 14 Aug 2026 | 21.85% | 14.39 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 22.41% | 10.39 | |
| 15 Sep 2026 | 23.06% | 8.31 |
See also: Inhibrx Biosciences, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.